Subscriber Login   Users   Administrators
Online CE, compliance, and document control for clinical and histology laboratories

Sample Page

The page below is a sample from the MediaLab course, Hemolytic Disease of the Fetus and Newborn.

Learn about Compliance & CE courses available for clinical laboratories and individual medical technologists.

Related Uses

RhIg is also indicated in these special circumstances:

  • Antepartum fetal maternal hemorrhage (FMH), suspected or proven as a result of placenta previa, amniocentesis, chorionic villus sampling, cordocentesis, other obstetrical manipulative procedures (e.g., external version or abdominal trauma such as may occur in a car accident or fall);
  • Therapeutic abortion;
  • Vaginal bleeding during pregnancy;
  • Loss, or threatened loss, of fetus at any gestational stage;
  • Ectopic pregnancy.

For these non-routine indications, depending on the level of medical care the pregnant woman receives or the awareness level of the risks involved, there is increased potential for RhIg to be administered inappropriately or not at all.

 

 

MediaLab, Inc.

http://www.MediaLabInc.net    |    (877) 776-8460 (tollfree)    |    sales@medialabinc.net